Amylyx Pharmaceuticals Inc's total assets for Q1 2026 were $293.60M, a decrease of -11.74% from the previous quarter. AMLX total liabilities were $20.44M for the fiscal quarter, a -25.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.